These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 8983345)

  • 1. Enhanced binding and inertness to dehalogenation of alpha-melanotropic peptides labeled using N-succinimidyl 3-iodobenzoate.
    Garg PK; Alston KL; Welsh PC; Zalutsky MR
    Bioconjug Chem; 1996; 7(2):233-9. PubMed ID: 8983345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorine-18-labeled [Nle4,D-Phe7]-alpha-MSH, an alpha-melanocyte stimulating hormone analogue.
    Vaidyanathan G; Zalutsky MR
    Nucl Med Biol; 1997 Feb; 24(2):171-8. PubMed ID: 9089709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a melanocortin receptor expressed by murine brain microvascular endothelial cells in culture.
    de Angelis E; Sahm UG; Ahmed AR; Olivier GW; Notarianni LJ; Branch SK; Moss SH; Pouton CW
    Microvasc Res; 1995 Jul; 50(1):25-34. PubMed ID: 7476577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [111In]-DTPA-labeled analogues of alpha-melanocyte-stimulating hormone for melanoma targeting: receptor binding in vitro and in vivo.
    Bagutti C; Stolz B; Albert R; Bruns C; Pless J; Eberle AN
    Int J Cancer; 1994 Sep; 58(5):749-55. PubMed ID: 8077062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodination of rhenium cyclized alpha-melanocyte-stimulating hormone resulting in enhanced radioactivity localization and retention in melanoma.
    Cheng Z; Chen J; Quinn TP; Jurisson SS
    Cancer Res; 2004 Feb; 64(4):1411-8. PubMed ID: 14973076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.
    Chen J; Cheng Z; Hoffman TJ; Jurisson SS; Quinn TP
    Cancer Res; 2000 Oct; 60(20):5649-58. PubMed ID: 11059756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the internalization of [125I-Tyr2, Nle4, D-Phe7] alpha-MSH following binding to the MSH receptor of B16 murine melanoma cells.
    Adams G; Olivier GW; Branch SK; Moss SH; Notarianni LJ; Pouton CW
    Ann N Y Acad Sci; 1993 May; 680():440-1. PubMed ID: 8390163
    [No Abstract]   [Full Text] [Related]  

  • 8. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
    Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
    J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological activity, binding, and metabolic fate of Ac-[Nle4, D-Phe7]alpha-MSH4-11NH2 with the F1 variant of B16 melanoma cells.
    Panasci LC; McQuillan A; Kaufman M
    J Cell Physiol; 1987 Jul; 132(1):97-103. PubMed ID: 3110178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substituted NDP-MSH peptides paired with mutant melanocortin-4 receptors demonstrate the role of transmembrane 6 in receptor activation.
    Fleck BA; Ling N; Chen C
    Biochemistry; 2007 Sep; 46(37):10473-83. PubMed ID: 17713970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged stimulation of S91 melanoma tyrosinase by [Nle4, D-Phe7]-substituted alpha-melanotropins.
    Abdel Malek ZA; Kreutzfeld KL; Marwan MM; Hadley ME; Hruby VJ; Wilkes BC
    Cancer Res; 1985 Oct; 45(10):4735-40. PubMed ID: 2992767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an internalizing monoclonal antibody labeled using N-succinimidyl 3-[131I]iodo-4-phosphonomethylbenzoate ([131I]SIPMB), a negatively charged substituent bearing acylation agent.
    Shankar S; Vaidyanathan G; Affleck DJ; Peixoto K; Bigner DD; Zalutsky MR
    Nucl Med Biol; 2004 Oct; 31(7):909-19. PubMed ID: 15464393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics.
    Al-Obeidi F; Castrucci AM; Hadley ME; Hruby VJ
    J Med Chem; 1989 Dec; 32(12):2555-61. PubMed ID: 2555512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The melanotropic peptide, [Nle4,D-Phe7] alpha-MSH, stimulates human melanoma tyrosinase activity and inhibits cell proliferation.
    Jiang J; Sharma SD; Nakamura S; Lai JY; Fink JL; Hruby VJ; Hadley ME
    Pigment Cell Res; 1995 Dec; 8(6):314-23. PubMed ID: 8789740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of conformational isomerism in alpha-melanocyte stimulating hormone by design of cyclic analogues.
    Nikiforovich GV; Sharma SD; Hadley ME; Hruby VJ
    Biopolymers; 1998 Sep; 46(3):155-67. PubMed ID: 9699465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent and prolonged melanotropic activities of the alpha-MSH fragment analog, Ac-[Nle4,D-Phe7]-alpha-MSH4-9-NH2.
    Klemes DG; Kreutzfeld KL; Hadley ME; Cody WL; Hruby VJ
    Biochem Biophys Res Commun; 1986 Jun; 137(2):722-8. PubMed ID: 3089218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
    Frändberg PA; Doufexis M; Kapas S; Chhajlani V
    Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites.
    Kopanchuk S; Veiksina S; Petrovska R; Mutule I; Szardenings M; Rinken A; Wikberg JE
    Eur J Pharmacol; 2005 Apr; 512(2-3):85-95. PubMed ID: 15840392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of alpha-melanocyte-stimulating hormone and its analog on the growth of human melanoma cell lines with different phenotypes].
    Morozova LF; D'iakov VL; Sukhanov VA
    Tsitologiia; 1993; 35(1):101-4. PubMed ID: 8386407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nle4, D-Phe7]-alpha-MSH: a superpotent melanotropin that "irreversibly" activates melanoma tyrosinase.
    Hadley ME; Abdel Malek ZA; Marwan MM; Kreutzfeld KL; Hruby VJ
    Endocr Res; 1985; 11(3-4):157-70. PubMed ID: 3009169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.